Open Access
Numéro
OCL
Volume 21, Numéro 3, May-June 2014
Numéro d'article D309
Nombre de pages 5
Section Dossier: Vitamin D, vitamin or hormone? / La vitamine D, vitamine ou hormone ?
DOI https://doi.org/10.1051/ocl/2013056
Publié en ligne 29 avril 2014
  • Abe E, Miyaura C, Sakagami H, et al. 1981. Differentiation of mouse myeloid leukemia cells induced by 1α,25-dihydroxyvitamin D3. Proc. Natl. Acad. Sci. USA 78: 4990-4994. [CrossRef] [Google Scholar]
  • Ananthakrishnan AN, Khalili H, Higuchi LM, et al. 2012. Higher predicted vitamin D status is associated with reduced risk of Crohn’s disease. Gastroenterology 142: 482-489. [CrossRef] [PubMed] [Google Scholar]
  • Bertolini DL, Araujo PR, Silva RN, Duarte AJ, Tzanno-Martins CB. 1999. Immunomodulatory effects of vitamin D analog KH1060 on an experimental skin transplantation model. Transplant. Proc. 31: 2998-2999. [CrossRef] [PubMed] [Google Scholar]
  • Björkhem I, Holmberg I. 1978. Assay and properties of a mitochondrial 25-hydroxylase active on vitamine D3. J. Biol. Chem. 253: 842-849. [PubMed] [Google Scholar]
  • Bouillon R, Carmeliet G, Verlinden L, et al. 2008. Vitamin D and human health: lessons from vitamin D receptor null mice. Endocr. Rev. 29: 726-776. [CrossRef] [PubMed] [Google Scholar]
  • Bouillon R, Eelen G, Verlinden L, Mathieu C, Carmeliet G, Verstuyf A. 2006. Vitamin D and cancer. J. Steroid. Biochem. Mol. Biol. 102: 156-162. [CrossRef] [PubMed] [Google Scholar]
  • Bouillon R, Okamura WH, Norman AW. 1995. Structure-function relationships in the vitamin D endocrine system. Endocrine Rev. 16: 200-257. [Google Scholar]
  • Cantorna MT, Humpal-Winter J, De Luca HF. 2000. In vivo regulation of interleukin-4 is one mechanism underlying the immunoregulatory effects of 1,25-dihydroxyvitamin D(3). Arch. Biochem. Biophys. 377: 135-138. [CrossRef] [PubMed] [Google Scholar]
  • Chen W, Chiang JY. 2003. Regulation of human sterol 27-hydroxylase gene (CYP27A1) by bile acids and hepatocyte nuclear factor 4alpha (HNF4alpha). Gene 313: 71-82. [CrossRef] [PubMed] [Google Scholar]
  • Cheng JB, Levine MA, Bell NH, Mangelsdorf DJ, Russell DW. 2004. Genetic evidence that the human CYP2R1 enzyme is a key vitamin D 25-hydroxylase. Proc. Natl. Acad. Sci. USA 101: 7711-7715. [CrossRef] [Google Scholar]
  • Cooke NC, Haddad JG. Vitamin D binding protein. In: Feldman D, Glorieux FH, Pike JW, eds. Vitamin D. San Diego, CA: Academic Press, 1997, pp. 87-101. [Google Scholar]
  • Cui Y, Rohan TE. 2006. Vitamin D, calcium and breast cancer risk: a review. Cancer Epidemiol. Biomarkers Prev. 15: 1427-1143. [CrossRef] [PubMed] [Google Scholar]
  • Davis CD, Hartmuller V, Freedman M, et al. 2007. Vitamin D and cancer: current dilemmas and future needs. Nutr. Rev. 65: S71-74. [CrossRef] [Google Scholar]
  • Deeb KK, Trump DL, Johnson CS. 2007. Vitamin D signalling pathways in cancer: potential for anticancer therapeutics. Nat. Rev. Cancer 7: 684-700. [CrossRef] [PubMed] [Google Scholar]
  • Eloranta JJ, Kullak-Ublick GA. 2005. Coordinate transcriptional regulation of bile acid homeostasis and drug metabolism. Arch. Biochem. Biophys. 433: 397-412. [CrossRef] [PubMed] [Google Scholar]
  • Gallo S, Rodd C, Weiler H. 2013. Vitamin D supplementation during first 12 months of life – reply. JAMA 310: 853-854. [CrossRef] [Google Scholar]
  • Garabédian M. 2000. La 1,25dihydroxyvitamine D et son récepteur. Rev. Rhum. 11: 315-319. [Google Scholar]
  • Garland CF, Gorham ED, Mohr SB, et al. 2007. Vitamin D and prevention of breast cancer: pooled analysis. J. Steroid. Biochem. Mol. Biol. 103: 708-711. [CrossRef] [PubMed] [Google Scholar]
  • Gorham ED, et al. 2007. Optimal vitamin D status for colorectal cancer prevention: a quantitative meta-analysis. Am. J. Prev. Med. 32: 210-216. [CrossRef] [PubMed] [Google Scholar]
  • Gregori S, Casorati M, Amuchastegui S, Smiroldo S, Davalli AM, Adorini L. 2001. Regulatory T cells induced by 1α, 25-dihydroxyvitamin D3 and mycophenolate mofetil treatment mediate transplantation tolerance. J. Immunol. 167: 1945-1953. [CrossRef] [PubMed] [Google Scholar]
  • Harjutsalo V, Sjoberg L, Tuomilehto J. 2008. Time trends in ẗhe incidence of type 1 diabetes in Finnish children: a cohort study. The Lancet 371: 1777-1782. [CrossRef] [Google Scholar]
  • Harris SS. 2005. Vitamin D in type I diabetes prevention. J. Nutr. 135: 323-325. [PubMed] [Google Scholar]
  • Holick MF, Garabédian, M. 2006. Vitamin D: Photobiology, Metabolism, Mechanism of action, and Clinical Applications in Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism, 6th edn. Washington: The American Society for Bone and Mineral Research, pp. 106-114. [Google Scholar]
  • Huang H, Porpodis K, Zarogoulidis P, et al. 2013. Vitamin D in asthma and future perspectives. Drug Des. Devel. Ther. 7: 1003-1013. [PubMed] [Google Scholar]
  • Hullett DA, Cantorna MT, Redaelli C, et al. 1998. Prolongation of allograft survival by 1,25-dihydroxyvitamin D3. Transplantation 66: 824-828. [CrossRef] [PubMed] [Google Scholar]
  • Johnsson C, Tufveson G. 1994. MC 1288 – a vitamin D analogue with immunosuppressive effects on heart and small bowel grafts. Transpl. Int. 7: 392-397. [PubMed] [Google Scholar]
  • Lappe JM, Travers-Gustafson D, Davies KM, Recker RR, Heaney RP. 2007. Vitamin D and calcium supplementation reduces cancer risk: results of a randomized trial. Am. J. Clin. Nutr. 85: 1586-1591. [PubMed] [Google Scholar]
  • Leheste JR, Melsen F, Wellner M, et al. 2003. Hypocalcemia and osteopathy in mice with kidney-specific megalin gene defect. FASEB J. 17: 247-249. [PubMed] [Google Scholar]
  • Lemire J. 2000. 1,25-dihydroxyvitamin D3: a hormone with immunomodulatory properties. Z. Rheumatol. 1: 24-27. [CrossRef] [Google Scholar]
  • Madhock TC, De Luca HF. 1979. Characteristics of the rat liver microsomal enzyme system converting cholecalciferol into 25-hydroxycholecalciferol. Evidence for the participation of cytochrome p-450. Biochem. J. 184: 491-499. [PubMed] [Google Scholar]
  • Manolagas SC, Hustmyer FG, Yu XP. 1990. Immunomodulating properties of 1,25-dihydroxyvitamin D3. Kidney Int. 29: S9-S16. [PubMed] [Google Scholar]
  • Mathieu C, Waer M, Casteels K, Laureys J, Bouillon R. 1995. Prevention of type I diabetes in NOD mice by nonhypercalcemic doses of a new structural analog of 1,25-dihydroxyvitamin D3, KH1060. Endocrinology 136: 866-872. [PubMed] [Google Scholar]
  • Munger KL, Levin LI, Hollis BW, Howard NS, Ascherio A. 2006. Serum 25-hydroxyvitamin D levels and risk of multiple sclerosis. JAMA 296: 2832-2838. [CrossRef] [PubMed] [Google Scholar]
  • Nagpal S, Na S, Rathnachalam R. 2005. Noncalcemic actions of vitamin D receptor ligands. Endocrine Rev. 26: 662-687. [CrossRef] [PubMed] [Google Scholar]
  • Nanzer AM, Chambers ES, Ryanna K, et al. 2013. Enhanced production of IL-17A in patients with severe asthma is inhibited by 1α, 25-dihydroxyvitamin D3 in a glucocorticoid-independent fashion. J. Allergy. Clin. Immunol. 132: 297-304. [CrossRef] [PubMed] [Google Scholar]
  • Nykjaer A, Dragun D, Walther D, et al. 1999. An endocytic pathway essential for renal uptake and activation of the steroid 25-(OH) vitamin D3. Cell 96: 507-515. [CrossRef] [PubMed] [Google Scholar]
  • Post SM, Duez H, Gervois PP, Staels B, Kuipers F, Princen HM. 2001. Fibrates suppress bile acid synthesis via peroxisome proliferator-activated receptor-alpha-mediated downregulation of cholesterol 7alpha-hydroxylase and sterol 27-hydroxylase expression. Arterioscler. Thromb. Vasc. Biol. 21: 1840-1845. [CrossRef] [PubMed] [Google Scholar]
  • Prosser DE, Jones G. 2004. Enzymes involved in the activation and inactivation of vitamin D. Trends Biochem. Sci. 29: 664-673. [CrossRef] [PubMed] [Google Scholar]
  • Quinn CM, Jessup W, Wong J, Kritharides L, Brown AJ. 2005. Expression and regulation of sterol 27-hydroxylase (CYP27A1) in human macrophages: a role for RXR and PPARgamma ligands. Biochem. J. 385: 823-830. [CrossRef] [PubMed] [Google Scholar]
  • Redaelli CA, Wagner M, Tien YH, et al. 2001. 1α, 25-Dihydroxycholecalciferol reduces rejection and improves survival in rat liver allografts. Hepatology 34: 926-934. [CrossRef] [PubMed] [Google Scholar]
  • Rizk-Rabin M, Zineb R, Zhor B, Michèle G, Jana P. 1994. Synthesis of and response to 1,25-dihydroxycholecalciferol by subpopulations of murine epidermalkeratinocytes: existence of a paracrine system for 1,25 dihydroxycholecalciferol. J. Cell. Physiol. 159: 131-141. [CrossRef] [PubMed] [Google Scholar]
  • Stamp TCB, Haddad G, Twigg CA. 1977. Comparison of oral 25-hydroxycholecalciferol, vitamin D, and ultraviolet light as determinants of circulating 25-hydroxyvitamin D. Lancet 1341-1343. [Google Scholar]
  • Van Etten E, Mathieu C. 2005. Immunoregulation by 1,25-dihydroxyvitamin D3: basic concepts. J. Steroid. Biochem. Mol. Biol. 97: 93-101. [CrossRef] [PubMed] [Google Scholar]
  • Wactawski-Wende J, Kotchen JM, Anderson GL, et al. 2006. Calcium plus vitamin D supplementation and the risk of colo-rectal cancer. N. Engl. J. Med. 354: 684-96. [CrossRef] [PubMed] [Google Scholar]
  • Webb AR, Holick MF. 1988. The role of sunlight in the cutaneous production of vitamin D3. Annu. Rev. Nutr. 8: 375-399. [CrossRef] [PubMed] [Google Scholar]
  • Windaus A, Linsert O. 1928. Vitamin D1. Ann. Chem. 465: 148. [CrossRef] [Google Scholar]

Les statistiques affichées correspondent au cumul d'une part des vues des résumés de l'article et d'autre part des vues et téléchargements de l'article plein-texte (PDF, Full-HTML, ePub... selon les formats disponibles) sur la platefome Vision4Press.

Les statistiques sont disponibles avec un délai de 48 à 96 heures et sont mises à jour quotidiennement en semaine.

Le chargement des statistiques peut être long.